Neil E. Fleshner

Neil E. Fleshner is a declared insider of POINT Biopharma Global Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 30 June 2021 to 22 December 2023, the count stands at 4 filings.

Sales make up the whole of the open-market record (1 sale, €4.0M). Besides market trades, the filings include 1 share grant.

Most recently, on 27 December 2023, the filings show a transaction in POINT Biopharma Global Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.